Pérdida de peso

Investigations MedDRA 10047895

Disminución no deseada del peso corporal, observada con agonistas del GLP-1, topiramato y quimioterapia.

Related Side Effects

Other effects in the Investigations category:

Aumento de peso

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.